NCT00211393View on ClinicalTrials.gov

A Pilot Study of the Treatment of Central Serous Chorioretinopathy With Ketoconazole

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

March 31, 2008

Study Completion Date

April 30, 2008

Conditions
Chronic Central Serous Chorioretinopathy
Interventions
DRUG

ketoconazole

600mg. /day for 6 weeks

Trial Locations (1)

10021

Manhattan Eye, Ear & Throat Hospital, New York

All Listed Sponsors
collaborator

LuEsther T. Mertz Retinal Research Center

OTHER

lead

Manhattan Eye, Ear & Throat Hospital

OTHER

NCT00211393 - A Pilot Study of the Treatment of Central Serous Chorioretinopathy With Ketoconazole | Biotech Hunter | Biotech Hunter